Tolbutamide

Generic Name
Tolbutamide
Brand Names
-
Drug Type
Small Molecule
Chemical Formula
C12H18N2O3S
CAS Number
64-77-7
Unique Ingredient Identifier
982XCM1FOI
Background

Tolbutamide is an oral antihyperglycemic agent used for the treatment of non-insulin-dependent diabetes mellitus (NIDDM). It is structurally similar to acetohexamide, chlorpropamide and tolazamide and belongs to the sulfonylurea class of insulin secretagogues, which act by stimulating β cells of the pancreas to release insulin. Sulfonylureas increase both ba...

Indication

For treatment of NIDDM (non-insulin-dependent diabetes mellitus) in conjunction with diet and exercise.

Associated Conditions
Type 2 Diabetes Mellitus
Associated Therapies
-
Clinical Trials
Related News

Gamma-Secretase/Notch Signalling Pathway Inhibitor RO4929097 in Treating Patients With Advanced Solid Tumors

First Posted Date
2010-10-11
Last Posted Date
2014-12-23
Lead Sponsor
National Cancer Institute (NCI)
Target Recruit Count
17
Registration Number
NCT01218620
Locations
🇺🇸

University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States

A Drug Interaction Study of Tasisulam in Patients With Advanced Cancer or Lymphoma

Phase 1
Terminated
Conditions
Lymphoma
Advanced Cancer
Interventions
Drug: Tolbutamide
Drug: Tasisulam
First Posted Date
2010-08-20
Last Posted Date
2018-10-19
Lead Sponsor
Eli Lilly and Company
Target Recruit Count
4
Registration Number
NCT01185548
Locations
🇬🇧

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician., London, United Kingdom

AZD2066 Cocktail Study

First Posted Date
2009-06-30
Last Posted Date
2009-10-27
Lead Sponsor
AstraZeneca
Target Recruit Count
15
Registration Number
NCT00930306
Locations
🇬🇧

Research Site, Manchester, United Kingdom

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy